Udvalgte videnskabelige publikationer 2017-2020

​1-Specovius S, Zimmermann HG, Oertel FC, Chien C et al. Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO). BMJ Open. 2020 Oct 29;10(10):e035397. doi:10.1136/bmjopen- 2019-035397.PMID: 33122310

2- Altintas A, Dargvainiene J, Schneider-Gold C, Asgari N et al. Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG). Ther Adv Neurol Disord. 2020 Aug 25;13:1756286420949808. doi: 10.1177/1756286420949808. eCollection 2020.

3- Owens T, Benmamar-Badel A, Wlodarczyk A, et al. Protective roles for myeloid cells in neuroinflammation. Scand J Immunol. 2020 Nov;92(5):e12963. doi: 10.1111/sji.12963. Epub 2020 Oct 7.PMID: 32851668
4- Olesen MN, Nilsson AC, Pihl-Jensen G, Soelberg KK, Olsen DA, Brandslund I, et al. Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13. Mult Scler Relat Disord. 2020;44:102281.
5- Chalmer TA, Buron M, Illes Z, Papp V, Theodorsdottir A, Schafer J, et al. Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2020;91(1):67-74.
6- Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, et al. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Front Neurol. 2020;11:501.
7- Khorooshi R, Tofte-Hansen EU, Tygesen C, Montanana-Rosell R, Limburg HL, Marczynska J, et al. Angiotensin AT2 receptor-induced interleukin-10 attenuates neuromyelitis optica spectrum disorder-like pathology. Multiple sclerosis. 2020;26(10):1187-96.
8- Tenembaum S, Yeh EA, Guthy-Jackson Foundation International Clinical C. Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis. Front Pediatr. 2020;8:339.
9- Ashtari F, Mehdipour R, Shaygannejad V, Asgari N. Pre-pregnancy, obstetric and delivery status in women with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2020;44:102252.
10- Olesen MN, Wuolikainen A, Nilsson AC, Wirenfeldt M, Forsberg K, Madsen JS, et al. Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation. 2020;7(3).
11- Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hummert MW, Ringelstein M, et al. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. Journal of Neuroinflammation. 2020;17(1):261.
12- Asgari N, Multidisciplinary aspects of Neuromyelitis Optica spectrum disorder (NMOSD), Syddansk Universitet, 2019 (DMSc. thesis)
13- Asgari N, Flanagan EP. Reader response: Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. Neurology. 2019 Oct 15;93(16):722-723.
14- Knudsen R, Gaunsbaek MQ, Schultz JH, Nilsson AC, Madsen JS, Asgari N. Vocal cord paralysis as primary and secondary results of malignancy. A prospective descriptive study. Laryngoscope Investig Otolaryngol. 2019 Jan 29;4(2):241-245
15- Olesen MN, Soelberg K, Debrabant B, Nilsson AC, Lillevang ST, Grauslund J, Brandslund I,
Madsen JS, Paul F, Smith TJ, Jarius S, Asgari N. Cerebrospinal fluid biomarkers for predicting
development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort
study. J Neuroinflammation. 2019 Mar 11;16(1):59.
16- Shaygannejad V, Fayyazi E, Badihian S, Mirmosayyeb O, Manouchehri N, Ashtari F, Asgari N. Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study. J Neurol. 2019 Mar;266(3):642-650.
17- Asgari N, Lillevang ST, Skejoe H.P.B, Kyvik K.O. Epidemiology of Neuromyelitis Optica Spectrum Disorder in Denmark (1998-2008, 2007-2014). Brain Behav. 2019 Jul;9(7):e01338.
18- Mohseni SH, Skejoe HPB, Wuerfel J, Paul F, Reindl M, Jarius S, Asgari N. Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient. Case Rep Neurol Med. 2018 Dec 9;2018:1365175.
19- Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B. [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]. J Neuroinflammation. 2018 May 3;15(1):134.
20- Kim SH, Mealy MA, Levy M, Schmidt F, Ruprecht K, Paul F, Ringelstein M, Aktas O, Hartung HP, Asgari N, Tsz-Ching JL, Siritho S, Prayoonwiwat N, Shin HJ, Hyun JW, Han M, Leite MI, Palace J, Kim HJ. Racial differences in neuromyelitis optica spectrum disorder. Neurology. 2018 Nov 27;91(22):e2089-e2099.
21- Soelberg K, Specovius S, Zimmermann HG, Grauslund J, Mehlsen JJ, Olesen C, Neve ASB, Paul F, Brandt AU, Asgari N. Optical coherence tomography in acute optic neuritis: A population-based study. Acta Neurol Scand. 2018 Dec;138(6):566-573.
22- Baghbanian SM, Asgari N, Sahraian, MA, et al. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment. J Neurol Sci. May 15 2018, Volume 388, Pages: 222-231   
23-Eskandarieh S, Nedjat S, Abdollahpour I, Azimi AR, Moghadasi AN, Asgari N, Sahraian MA. Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study. Acta Neurol Belg. 2018 Jun;118(2):277-287.
24- Mørch MT, Sørensen SF, Khorooshi R, Asgari N, Owens T. Selective localization of IgG from cerebrospinal fluid to brain parenchyma. J Neuroinflammation. 2018 Apr 17;15(1):110.
25- Soelberg K, Nilsson AC, Nielsen C, Jarius S, Reindl M, Wildemann B, Lillevang ST, Asgari N. Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based. Mult Scler Relat Disord. 2018 Apr; 21:97-102.
26- Abdollahpour I, Nedjat S, Mansournia MA, Sahraian MA, Asgari N. Parental ethnicity associated with risk for multiple sclerosis: Mult Scler Relat Disord. 2018 Jan 17;20:100-103
27- Soelberg K, Skejoe HPB, Grauslund J, Smith TJ, Lillevang ST, Jarius S, Wildemann B, Paul F, Asgari N. Magnetic resonance imaging findings at the first episode of acute optic neuritis. Mult Scler Relat Disord. 2017 Dec 25;20:30-36.
28- Sahraian MA, Moghadasi AN, Azimi AR, Asgari N, H Akhoundi F, et.al. Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Mult Scler Relat Disord. 2017 Nov;18:144-151.
29- Soelberg K, Jarius S, Skejoe H, Engberg H, Mehlsen JJ, Nilsson AC, Madsen JS, Reindl M, Wildemann B, Grauslund J, Kyvik KO, Smith TJ, Lillevang ST, Paul F, Weinshenker BG,
Asgari N. A population-based prospective study of optic neuritis. Mult Scler. 2017 Dec;23(14):1893-1901.
30- Nikoo Z, Badihian S, Shaygannejad V, Asgari N, Ashtari F. Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial.
J Neurol. 2017 Sep;264(9):2003-2009.
31- Berg CT, Khorooshi R, Asgari N, Owens T. Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination. J Neuroinflammation. 2017 Jun 24;14(1):127.
32- Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG. Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2017 Apr 21;4(4):e343.
33- Asgari N, Jarius S, Laustrup H, Skejoe HP, Lillevang ST, Weinshenker BG, Voss A. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study. Mult Scler. 2017 Mar 1:1352458517699791.


Fik du svar på dit spørgsmål?

Link til denne side:
Andre sider under Center for Neurologisk forskning